Wenle Zhao to Computer Simulation
This is a "connection" page, showing publications Wenle Zhao has written about Computer Simulation.
Connection Strength
0.910
-
Statistical properties of minimal sufficient balance and minimization as methods for controlling baseline covariate imbalance at the design stage of sequential clinical trials. Stat Med. 2020 08 30; 39(19):2506-2517.
Score: 0.132
-
Imbalance control in clinical trial subject randomization-from philosophy to strategy. J Clin Epidemiol. 2018 09; 101:116-118.
Score: 0.113
-
Mass weighted urn design--A new randomization algorithm for unequal allocations. Contemp Clin Trials. 2015 Jul; 43:209-16.
Score: 0.094
-
Comparison of statistical and operational properties of subject randomization procedures for large multicenter clinical trial treating medical emergencies. Contemp Clin Trials. 2015 Mar; 41:211-8.
Score: 0.091
-
A better alternative to stratified permuted block design for subject randomization in clinical trials. Stat Med. 2014 Dec 30; 33(30):5239-48.
Score: 0.088
-
Managing competing demands in the implementation of response-adaptive randomization in a large multicenter phase III acute stroke trial. Stat Med. 2014 Oct 15; 33(23):4043-52.
Score: 0.087
-
Flexible analytical methods for adding a treatment arm mid-study to an ongoing clinical trial. J Biopharm Stat. 2012; 22(4):758-72.
Score: 0.074
-
Block urn design - a new randomization algorithm for sequential trials with two or more treatments and balanced or unbalanced allocation. Contemp Clin Trials. 2011 Nov; 32(6):953-61.
Score: 0.072
-
Quantitative comparison of randomization designs in sequential clinical trials based on treatment balance and allocation randomness. Pharm Stat. 2012 Jan-Feb; 11(1):39-48.
Score: 0.071
-
Impact of adaptation algorithm, timing, and stopping boundaries on the performance of Bayesian response adaptive randomization in confirmative trials with a binary endpoint. Contemp Clin Trials. 2017 11; 62:114-120.
Score: 0.027
-
The impact of covariate adjustment at randomization and analysis for binary outcomes: understanding differences between superiority and noninferiority?trials. Stat Med. 2015 May 20; 34(11):1834-40.
Score: 0.023
-
Impact of safety monitoring on error probabilities of binary efficacy outcome analyses in large phase III group sequential trials. Pharm Stat. 2012 Jul-Aug; 11(4):310-7.
Score: 0.019
-
Measuring continuous baseline covariate imbalances in clinical trial data. Stat Methods Med Res. 2015 Apr; 24(2):255-72.
Score: 0.018